EXCLUSIVE: RenovoRx Concludes Enrollment in Phase 3 Trial of RenovoCath Drug-Delivery Device for Locally Advanced Pancreatic Cancer; Topline Data Readout Expected in 2H 2027

뉴스 본문을 불러오고 있어요.

EXCLUSIVE: RenovoRx Concludes Enrollment in Phase 3 Trial of RenovoCath Drug-Delivery Device for Locally Advanced Pancreatic Cancer; Topline Data Readout Expected in 2H 2027 | 웨이프 WAPE

EXCLUSIVE: RenovoRx Concludes Enrollment in Phase 3 Trial of RenovoCath Drug-Delivery Device for Locally Advanced Pancreatic Cancer; Topline Data Readout Expected in 2H 2027

기사 요약

관련 종목

댓글 —